What distinguishes our study is the novel evidence linking AF to the Wnt3a/β‐catenin signalling pathway under pressure overload conditions, offering promise as a potential target for preventing and treating pressure overload‐induced AF. This evidence concerns the gene WNT3A and atrial fibrillation.